Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego (Q.M.B., M.B., E.A.).
Division of Cardiology, Department of Medicine, University of Colorado, Aurora (L.A.A.).
Circ Heart Fail. 2019 Jul;12(7):e006058. doi: 10.1161/CIRCHEARTFAILURE.119.006058. Epub 2019 Jun 19.
Advanced heart failure therapies, including heart transplantation and durable mechanical circulatory support, are available to a limited number of patients because of the scarcity of donors, expense, and large burden of care. The importance of psychological and social determinants of health, including cognitive status, health literacy, psychopathology, social support, medical adherence, and substance abuse, are emphasized in advanced heart failure and further amplified in the context of mechanical circulatory support and heart transplantation. The psychosocial assessment of advanced heart failure therapy candidates remains largely subjective, requiring a multidisciplinary evaluation, which may include psychiatrists, social workers, case managers, financial coordinators, pharmacists, and clinicians. Objective tools-including the Stanford Integrated Psychosocial Assessment for Transplantation, Psychosocial Assessment of Candidates for Transplantation, and Transplant Evaluation Rating Scale-were developed and validated in limited populations to help standardize the evaluation process. Small, retrospective studies have inconsistently shown that these tools may predict clinical outcomes in the transplant population, with higher-risk scores associated with readmissions, rejection episodes, and infections. However, it has been more difficult to show that these tools can predict mortality, and their applicability to the mechanical circulatory support population is less studied. The International Society for Heart and Lung Transplantation released a consensus statement in 2018 to promote consistency of psychosocial evaluation across advanced heart failure programs, but it lacks specific recommendations given the current state of evidence. This state-of-the-art review expands on the current consensus by critically reviewing current studies supporting available objective assessment tools, proposing a psychosocial evaluation framework that uses a multidisciplinary approach and offering future directions for research.
先进的心力衰竭治疗方法,包括心脏移植和持久的机械循环支持,由于供体稀缺、费用高昂和护理负担沉重,只有少数患者能够获得。在机械循环支持和心脏移植的背景下,健康的心理和社会决定因素(包括认知状态、健康素养、精神病理学、社会支持、医疗依从性和药物滥用)的重要性也得到了强调。先进的心力衰竭治疗候选者的社会心理评估在很大程度上仍然是主观的,需要多学科评估,可能包括精神科医生、社会工作者、个案经理、财务协调员、药剂师和临床医生。一些客观的工具,包括斯坦福综合移植心理社会评估、移植候选者心理社会评估和移植评估评分量表,已经在有限的人群中开发和验证,以帮助标准化评估过程。小型回顾性研究结果不一致,这些工具可能预测移植人群的临床结果,高风险评分与再入院、排斥发作和感染有关。然而,更难证明这些工具可以预测死亡率,并且它们在机械循环支持人群中的适用性研究较少。国际心肺移植协会在 2018 年发布了一项共识声明,以促进先进心力衰竭项目中社会心理评估的一致性,但鉴于目前证据的状况,该声明缺乏具体建议。这篇最新综述通过批判性地回顾支持现有客观评估工具的现有研究,扩展了当前的共识,提出了一个使用多学科方法的社会心理评估框架,并为未来的研究提供了方向。